Using gene-environment interactions to target personalized treatment in mood disorder

Personalized Medicine
Torsten Klengel, Elisabeth B Binder

Abstract

Mood disorders account for a substantial social and financial burden on society. Although considerable efforts to delineate the underlying pathophysiological pathways have been undertaken during the last decades, only very limited progress on diagnostic and treatment algorithms have been achieved. High hopes have been put into genetics research to elucidate the pathogenesis of mood disorders, but so far, only small and inconsistent associations could be reported. Epidemiologic and family studies have always emphasized the importance of environmental factors; especially the impact of childhood trauma in mood disorders and more recently a number of specific gene-environment interactions have been reported. It is thus likely that the combination of a patient's life history and genetic susceptibility as well as other laboratory markers might provide a better insight into mental diseases and their treatment options. In this article, we discuss the concept of gene-environment interactions in major depression and their putative role in treatment response and personalized therapy.

References

Jun 1, 1995·The American Journal of Psychiatry·K S KendlerL J Eaves
Jun 1, 1996·The Psychiatric Clinics of North America·M Fava, K G Davidson
Sep 29, 2000·The American Journal of Psychiatry·P F SullivanK S Kendler
Jan 6, 2001·Neuron·M Fava, K S Kendler
Nov 15, 2003·Proceedings of the National Academy of Sciences of the United States of America·Charles B NemeroffMartin B Keller
May 4, 2004·The American Journal of Psychiatry·Anil K MalhotraJames L Kennedy
Sep 2, 2004·Nature Reviews. Drug Discovery·Richard Weinshilboum, Liewei Wang
Nov 26, 2004·Proceedings of the National Academy of Sciences of the United States of America·Joan KaufmanJoel Gelernter
Dec 4, 2004·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Jessica A Lasky-SuMing T Tsuang
Jun 14, 2005·Progress in Neuro-psychopharmacology & Biological Psychiatry·Marcus IsingFlorian Holsboer
Nov 23, 2005·Biological Psychiatry·Douglas F Levinson
Jan 5, 2006·The American Journal of Psychiatry·Madhukar H TrivediUNKNOWN STAR*D Study Team
Jan 5, 2006·The American Journal of Psychiatry·Kenneth S KendlerCarol A Prescott
Mar 7, 2006·Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists·Karleyton C EvansScott L Rauch
Apr 6, 2006·Handbook of Experimental Pharmacology·E B Binder, F Holsboer
Sep 20, 2006·Nature Reviews. Genetics·Teri A ManolioFrancis S Collins
Oct 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Turhan CanliKlaus Peter Lesch
Apr 25, 2007·Nature Reviews. Neuroscience·Nadia TsankovaEric J Nestler
Apr 27, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Murray B SteinJoel Gelernter
May 1, 2007·Journal of Affective Disorders·Sergi PapiolLourdes Fañanás
Aug 28, 2007·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Shih-Jen TsaiYounger W-Y Yu
Sep 4, 2007·Psychosomatic Medicine·Beverly H BrummettRedford B Williams
Nov 7, 2007·Proceedings of the National Academy of Sciences of the United States of America·Avshalom CaspiTerrie E Moffitt
Jan 9, 2008·Experimental and Clinical Psychopharmacology·Marcus Ising, Florian Holsboer
Feb 6, 2008·Archives of General Psychiatry·Rebekah G BradleyKerry J Ressler
Mar 20, 2008·JAMA : the Journal of the American Medical Association·Elisabeth B BinderKerry J Ressler
May 10, 2008·Expert Review of Proteomics·Firas H KobeissyKevin K W Wang
May 20, 2008·Annals of Medicine·Jun-ichi IgaTetsuro Ohmori
May 27, 2008·Journal of Affective Disorders·Jamie VaskeJohn Paul Wright
Jul 4, 2008·Pharmacogenomics·Julia KirchheinerJürgen Brockmöller
Jul 12, 2008·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·D A MrazekR M Weinshilboum
Jul 17, 2008·Nature Reviews. Neuroscience·Florian Holsboer
Aug 12, 2008·Biological Psychiatry·Marcus R MunafòJonathan Flint
Aug 16, 2008·The European Journal of Neuroscience·Marcus IsingFlorian Holsboer
Sep 19, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jose de Leon

❮ Previous
Next ❯

Citations

Dec 27, 2011·Current Psychiatry Reports·Robert Keers, Rudolf Uher
Feb 28, 2013·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Torsten Klengel, Elisabeth B Binder
Dec 15, 2012·The International Journal of Neuropsychopharmacology·Torsten Klengel, Elisabeth B Binder

❮ Previous
Next ❯

Methods Mentioned

BETA
environmental stress

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Best Practice & Research. Clinical Gastroenterology
Séverine Vermeire
JAMA : the Journal of the American Medical Association
Nina RieckmannJacqueline Müller-Nordhorn
JAMA : the Journal of the American Medical Association
Christian Schwahn, Hans Jörgen Grabe
© 2022 Meta ULC. All rights reserved